India's Jagsonpal Pharma surges on strong Q3 results
23/01/2025 05:18
** Jagsonpal Pharmaceuticals JGSN.NS jumps 7% to 244
rupees
** Co's Q3 profit jumps nearly three-fold, helped by strong
sales of gynaecology products
** About 900,000 shares traded in stock's most active
session since Dec. 3, 2024
** JGSN marginally up YTD; had risen 57% in 2024
(Reporting by Sethuraman NR in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on Jagsonpal Pharmaceuticals
See all newsIndia's Jagsonpal Pharma jumps on purchase of wellness portfolio of Group Pharma
Brief: Jagsonpal Pharmaceuticals To Buy Wellness Portfolio Of Group Pharmaceuticals
Brief: Jagsonpal Pharmaceuticals Passes Buy-Back Resolution
Brief: Jagsonpal Pharmaceuticals Gets Order For Tax Demand Of 48.2 Million Rupees
India's Jagsonpal Pharmaceuticals jumps after plan to buyback shares